Update: AbbVie Q3 Adjusted Earnings, Revenue Rise; Fiscal 2026 Adjusted EPS Guidance Raised

08:36 AM EDT, 10/30/2026 (MT Newswires) -- (Updates to add details on dividend in the sixth paragraph.) AbbVie (ABBV) reported Q3 adjusted earnings Friday of $3.82 per diluted share, up from $1.86 a year earlier. Analysts polled by FactSet expected $3.73. Revenue for the quarter ended Sept. 30 was $17.40 billion, up from $15.78 billion a year earlier. Analysts expected revenue of $17.32 billion. The company raised its fiscal 2026 adjusted earnings outlook to $13.95 to $13.99 per diluted share, from $13.76 to $13.96 previously. Analysts surveyed by FactSet expect $13.91. The company also raised its quarterly dividend by 5.2% to $1.82 per share, payable Feb. 16, 2027 to holders of record Jan. 15, 2027.